Compare Medpace Holdings Inc (MEDP) vs Financial Select Sector SPDR Fund (XLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Financial Select Sector SPDR Fund — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Financial Select Sector SPDR Fund trades at $54.73 (market cap $50.06B). The key difference: Financial Select Sector SPDR Fund is far larger — about 3× Medpace Holdings Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Financial Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Financial Select Sector SPDR Fund for 104 Days on average.
| MEDP | XLF | |
|---|---|---|
Market Cap | $16.82B | $50.06B |
Volume | 223,093 | 47,464,120 |
Sector | Health | — |
52-Week High | $630.19 | $58.55 |
52-Week Low | $393.42 | $47.80 |
Typical Hold Time | 14 Days | 104 Days |
Enterprise Value | $16.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $602.70, down slightly by 0.26% on the day, with a neutral technical outlook and bullish moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected on October 21, 2026. Revenue and net income are projected to grow in 2026, supported by a robust 17.67% net income margin and exceptional ROE of 162.15%. However, valuation ratios like P/E of 35.41 and P/B of 38.77 suggest a premium pricing relative to peers.
The stock offers upside to the consensus price target of $620.44, but risks include high valuation multiples, CEO stock sales, and mixed institutional positioning. Investors should weigh strong profitability against potential overvaluation and monitor Q3 earnings for continued momentum.
XLF trades at $54.23, up 0.89% with a bearish technical signal from moving averages despite neutral oscillators. The financial sector faces headwinds as bank stocks lag the S&P 500 by the widest margin since 1990 (24/7 Wall Street, 2026-10-02), though rising interest rates create potential tailwinds for financial institutions. Support levels cluster around $53-54 with resistance at $55.
The ETF's outlook balances interest rate benefits against sector underperformance risks. Key opportunities include Fed stress test transparency (Reuters, 2026-09-30) and institutional rotation into financials (Seeking Alpha, 2026-08-22), while regulatory uncertainty and political gridlock pose challenges for near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Financial Select Sector SPDR Fund
The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →
